Uses of Phenytoin
Phenytoin is primarily used for treating epilepsy, particularly generalized tonic-clonic seizures, partial seizures with or without generalization, and status epilepticus, with its primary mechanism of action being the modulation of voltage-gated sodium channels in neuronal cell membranes. 1, 2
Primary Indications
Seizure Management:
- Generalized tonic-clonic seizures
- Partial seizures (simple partial, complex partial)
- Status epilepticus (as part of treatment protocol)
- Serial seizures
Specific Clinical Scenarios:
- Seizure prophylaxis after subarachnoid hemorrhage
- Management of seizures in alcohol withdrawal
- Treatment of refractory status epilepticus (high-dose phenytoin up to 30 mg/kg)
Dosing Protocols
Adult Dosing
- Standard maintenance dosage: 300-400 mg/day (typically one 100-mg capsule three to four times daily)
- Once-daily dosing option: 300 mg daily (only with extended phenytoin sodium capsules)
- Loading dose: 1 gram divided into three doses (400 mg, 300 mg, 300 mg) administered at two-hour intervals in controlled settings 1
Pediatric Dosing
- Initial dose: 5 mg/kg/day in two or three equally divided doses
- Maintenance dose: 4-8 mg/kg/day (maximum 300 mg daily)
- Children >6 years: May require minimum adult dose (300 mg/day) 1
Status Epilepticus Dosing
- Standard dose: 18-20 mg/kg IV with 56% success rate
- High-dose option: Up to 30 mg/kg (as recommended by the Epilepsy Foundation of America's Working Group) before switching to alternative agents 3, 4
Pharmacokinetics
- Plasma half-life: Averages 22 hours (range 7-42 hours)
- Steady-state achievement: 7-10 days after initiation of therapy
- Protein binding: 90-95% protein-bound in plasma
- Therapeutic serum levels: 10-20 mcg/mL
- Metabolism: Almost completely metabolized in the liver 1, 2
Comparative Efficacy
- Phenytoin shows comparable efficacy to valproate for partial onset seizures and generalized tonic-clonic seizures 5
- In status epilepticus, phenobarbital has shown equal efficacy when compared with lorazepam, phenytoin, and phenytoin plus diazepam 3
Administration Routes
- Oral: Extended capsules, prompt capsules, suspension
- Intravenous: Direct IV administration (requires careful monitoring)
- Intramuscular: Fosphenytoin (prodrug) can be administered IM with complete absorption and rapid conversion to phenytoin 6
Monitoring Requirements
- Serum level monitoring: Recommended when:
- Initiating therapy (after 7-10 days)
- Changing dosage
- Adding/removing other medications
- Suspecting toxicity or non-compliance
- Trough levels: Obtained just before next scheduled dose
- Peak levels: 4-12 hours after administration 1
Adverse Effects and Cautions
- Neurological: Phenytoin encephalopathy, cognitive impairment, cerebellar syndrome
- Cardiovascular: Hypotension, cardiac dysrhythmias
- Local reactions: Purple glove syndrome (with IV administration)
- Long-term concerns: Not recommended for patients with:
Special Considerations
- Saturation kinetics at high plasma levels can lead to disproportionate increases in serum levels with small dose increases
- Careful monitoring needed when switching between different phenytoin formulations due to differences in bioavailability
- Not recommended as first-line therapy except in status epilepticus management 1, 2
Phenytoin's primary mechanism of action involves inhibiting voltage-sensitive sodium channels in the plasma membrane of neurons, which stabilizes the threshold against hyperexcitability and prevents the spread of seizure activity 7.
AI Assistant: I've provided a comprehensive overview of phenytoin's uses, focusing on its primary role in seizure management while including important information about dosing, monitoring, and safety considerations.